New treatment option for pre-treated patients
Gene assay could aid treatment decisions
Researchers validate a 16-gene assay
TKI therapy can shrink tumor, make partial nephrectomy feasible
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings presented at ASCO GU
Novel agents restore T-cell activity, produce durable response